The following main resolutions were passed at the General Meeting:

The parent company's and the group's income statements and balance sheets were adopted and it was resolved to discharge those who have held the position as members of the Board of Directors and Chief Executive Officer during the financial year 2024 from liability.

The General Meeting resolved, in accordance with the Board of Directors' proposal, on a dividend of SEK 4.75 per share for the financial year 2024. The record date for the dividend was set to May 16, 2025, and the dividend is expected to be distributed by Euroclear Sweden AB on May 21, 2025.

The General Meeting resolved, in accordance with the Nomination Committee's proposal, that the Board of Directors shall consist of seven members elected by the Annual General Meeting. The General Meeting resolved to re-elect Johan Strid, Christer Parkegren, Pia Sandvik, Ebba Fåhraeus, Robert Demark, Christer Wallberg and Magnus Lundin as members of the Board of Directors. Christer Parkegren was re-elected as Chair of the Board. The General Meeting also resolved to re-elect the accounting firm Ernst & Young AB, with Per Modin as Auditor in charge.

The General Meeting resolved, in accordance with the Nomination Committee's proposal, that remuneration to the Board of Directors, for the coming term of office, shall be paid with SEK 500,000 to the Chair of the Board and with SEK 250,000 to each of the other ordinary members of the Board of Directors elected by the Annual General Meeting and who are not employees of the company. Fees to the auditor shall be paid in accordance with invoices approved by the company.

The General Meeting resolved, in accordance with the Board of Directors' proposal, to approve the Remuneration Report.

The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to resolve on new issues of a maximum of 1,288,523 shares of class B, which corresponds to approximately 10 per cent of the total number of shares in the company at the time of the General Meeting. New issues of shares may be made with or without derogation from the shareholders' pre-emption rights, against payment in cash or with provision for payment in kind or set-off or otherwise subject to conditions.

The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors, on one or several occasions for the period until the next Annual General Meeting, to resolve to acquire own shares of class B so that the company's holding of own shares in total amounts to not more than one tenth of all the shares in the company.

The General Meeting resolved, in accordance with the Board of Directors' proposal, to implement an incentive program in the form of a warrant program (LTI 2025/2028) comprising key employees in the Prevas group. In total, the program is estimated to comprise a maximum of 500,000 warrants. Each warrant entitles the holder to subscribe for one new share of class B in the company at an exercise price corresponding to an amount amounting to 130 per cent of the volume-weighted average price of the company's share during a period of 21 trading days between April 11, 2025, and May 14, 2025. The warrants shall be transferred on market terms at a price (premium) determined on the basis of a calculated market value for the warrants by application of a generally accepted valuation model (Black & Scholes). The warrants may be exercised to subscribe for new shares during a period of two weeks from the date of publication of the interim report for the period April 1 - June 30, 2028, however no later than two weeks from and including August 31, 2028.

Notice of the Annual General Meeting and proposals for resolutions are available at https://www.prevas.com/IR/Annual-General-Meeting.